SEC Hits InterMune Exec With Insider Trading Suit
The U.S. Securities and Exchange Commission on Thursday filed suit against a former director of pharmaceutical company InterMune Inc., alleging he and his friends made more than $1 million using insider...To view the full article, register now.
Already a subscriber? Click here to view full article